Neopharm Labs Revenue and Competitors

Founded in 1990, Neopharm is a full service GMP analytical testing laboratory serving the global pharmaceutical industry as well as natural health products, medical marijuana, veterinary and cosmetics markets. From our government-accredited operations, we provide unique quality control and consulting services, as well as perform a wide variety of analysis, including fine chemistry, microbiology, sterility testing, method development and validation, technology transfer, and stability studies. Over the years, Neopharm has successfully developed/validated/transferred in excess of 3,000 analytical procedures. \r\n\r\nAs a Health Canada certified laboratory, Neopharm benefits an unique Canadian profile as a participant to the Global Mutual Recognition Agreements (MRA’s), covering drug/medicinal products, Good Manufacturing Practice (GMP), Compliance Program, with parties such as the European Community (EC), the European Economic Area – European Free Trade Association (EEA EFTA), as well as Switzerland and Australia. Countries where MRA’s are in place will accept Certificates of Analysis (CofA’s) produced by Neopharm for the local commercialization of foreign products.\r\n\r\nMISSION STATEMENT\r\n\r\nBy nurturing a culture of excellence Neopharm intends to establish itself as the best-in-class full service provider of Just-In-Time analytical services for the local and international markets. \r\n\r\nVISION STATEMENT\r\n\r\nThrough recruitment of qualified staff and continuous training, as well as investments in modern and state-of-the-art technologies, Neopharm provides value added services to its clients and acts as an extension of their product development, manufacturing and commercial operations.